Brief

On February 6, a public hearing was held in Brasília to discuss proposals for public consultation regarding the review of regulatory standards for industrialized herbal medicines. The Anvisa presented the process of constructing proposed normative changes as part of the National Policy on Medicinal and Herbal Plants, aiming to improve access to safe, effective, and quality herbal medicines.

This content is restricted.

Highlights content goes here...

This content is restricted.

National Health Surveillance Agency (Anvisa)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies